16
Jan
2024
09:00
GMT
Webinar
Intravascular Ultrasound-Guided Management of Diffuse Stenosis
00
Days
00
Hours
00
Mins
00
Secs
Faculty:
Javier Escaned
Overview
Diffuse stenoses present a unique set of challenges related to accurate vessel sizing in the setting of remodelling, the identification of disease in segments that appear angiographically normal and achievement of optimal stent implantation both in terms of luminal dimensions and stent apposition.
As the absence of a well-defined workflow has likely hampered more widespread uptake of intravascular ultrasound (IVUS) in this setting, this webinar proposes a workflow algorithm that can help support research and clinical decision making.
This webinar is supported by
Educational Objectives
- Overcoming the challenges of diffuse stenoses treated with percutaneous coronary intervention (PCI)
- Defining a workflow algorithm that can help support research and clinical decision making
- Implementing a single, comprehensive approach towards contemporary intracoronary assessment and physiological interrogation
Target Audience
- Interventional cardiologists, EU-wide
Faculty Biographies
Javier Escaned
Prof Javier Escaned is Head of the Interventional Cardiology Section at Hospital Clinico San Carlos (Madrid, Spain). He trained as a cardiologist in the United Kingdom (Queen Elizabeth University Hospital, Birmingham and Walsgrave Hospital, Coventry) before moving to the Thoraxcenter/Rotterdam (The Netherlands), where he obtained his PhD degree in 1994.
He has authored over 300 scientific articles, books and book chapters on different aspects of interventional cardiology; his latest contribution is Coronary Stenosis. Imaging, Structure and Physiology, a large textbook endorsed by the European Association of Percutaneous Cardiovascular Interventions/European Society of Cardiology (EAPCI/ESC), with its latest edition published in 2015. His main interests in the field of interventional cardiology include intracoronary imaging and physiology, complex percutaneous coronary intervention including chronic total occlusion recanalisation, and acute coronary syndromes.
He is currently principal investigator in the SYNTAX II and DEFINE FLAIR multicentre studies. Current and recent positions in scientific organisations include co-director of EuroPCR, board member of the EAPCI, nucleus member of the ESC Working Group on Pathophysiology and Microcirculation and board member of the EuroCTO Club.